AGP Executive Report
Last update: 2 hours agoBiotech Deals: Nanexa struck a global exclusive license and collaboration with Novo Nordisk worth up to $1.33B for its Pharmashell long-acting injectable platform, aiming at obesity and cardiometabolic drugs. Cancer Tech: Osaka Metropolitan University reports laser-boosted antibody–antigen binding that detects the colorectal cancer biomarker CEACAM-5 in minutes, targeting faster, more sensitive blood tests. AI in Healthcare & Research: University of Toledo built a browser tool to speed AI-assisted qualitative analysis of open-ended survey data, tackling the manual-coding bottleneck. Public Health: Researchers argue suicide prevention should focus less on predicting individual risk and more on reducing access to lethal means. AI & Education: Kean University launched New Jersey’s first AI bachelor’s major, with coursework spanning LLMs, ethics, and applied areas like cybersecurity and health. AI Governance/Legal: A new piece warns that AI-generated legal content can introduce fake citations and precedents into court filings. Markets: Stocks edged up as crude oil fell and chip/AI optimism supported sentiment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
